# FDA Inspection 1226486 - BioLife Plasma Services L.P. - December 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/6e8aa87a-12d5-47ec-bf05-967d4efe04a2
Source feed: FDA_Inspections

> FDA Inspection 1226486 for BioLife Plasma Services L.P. on December 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226486
- Company Name: BioLife Plasma Services L.P.
- Inspection Date: 2023-12-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1106696 - 2019-10-17](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/ca9642cc-1372-4c78-88ec-5cd7399e1608)
- [FDA Inspection 1017189 - 2017-06-14](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/f89330ba-ac2b-469b-96f4-4863e20f5ae9)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/a55b2950-6bf2-4868-8d8c-de08e5b84506

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d